[Effect of phenelzine on the toxicity of cholinergic drugs modified by reserpine].
D000818:Animals; D002800:Cholinesterase Inhibitors; D004347:Drug Interactions; D005260:Female; D005702:Galantamine / Q000633:toxicity; D007531:Isoflurophate / Q000633:toxicity; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors; D009388:Neostigmine / Q000633:toxicity; D010261:Paraoxon / Q000633:toxicity; D010277:Parasympathomimetics / Q000633:toxicity*; D010624:Phenelzine / Q000494:pharmacology*; D010830:Physostigmine / Q000633:toxicity; D012110:Reserpine / Q000494:pharmacology*; D014116:Toxicology
D002800:Cholinesterase Inhibitors; D008996:Monoamine Oxidase Inhibitors; D010277:Parasympathomimetics; D005702:Galantamine; D007531:Isoflurophate; D009388:Neostigmine; D012110:Reserpine; D010830:Physostigmine; D010624:Phenelzine; D010261:Paraoxon
Der Einfluss von Phenelzin auf die durch Reserpin veränderte Toxizität cholinerger Pharmaka.